In our results, therapeutic targets or biomarkers of neurological disorder and mental disorder, such as DRD1, DRD2, DRD4, HTR2A, PRL and ADRA2A, were assigned with high scores in both mirtazapine and pramipexole (Fig. 4a and b). Here, ADRA2A is linked to nervous system disorder.